Welcome to LookChem.com Sign In|Join Free

CAS

  • or

53064-79-2

Post Buying Request

53064-79-2 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

53064-79-2 Usage

Chemical Properties

Pale Yellow Liquid

Uses

Iodomethyl pivalate can be used as reagent used for the addition of pivaloyl group.

Synthesis Reference(s)

The Journal of Organic Chemistry, 48, p. 5280, 1983 DOI: 10.1021/jo00174a024

Check Digit Verification of cas no

The CAS Registry Mumber 53064-79-2 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,3,0,6 and 4 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 53064-79:
(7*5)+(6*3)+(5*0)+(4*6)+(3*4)+(2*7)+(1*9)=112
112 % 10 = 2
So 53064-79-2 is a valid CAS Registry Number.
InChI:InChI=1/C6H11IO2/c1-6(2,3)5(8)9-4-7/h4H2,1-3H3

53064-79-2SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 12, 2017

Revision Date: Aug 12, 2017

1.Identification

1.1 GHS Product identifier

Product name Iodomethyl Pivalate

1.2 Other means of identification

Product number -
Other names Iodomethyl pivalate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:53064-79-2 SDS

53064-79-2Synthetic route

Chloromethyl pivalate
18997-19-8

Chloromethyl pivalate

iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

Conditions
ConditionsYield
With sodium iodide; calcium chloride In ethyl acetate at 78℃; for 6h;94%
With sodium iodide In acetonitrile at 30℃; for 5h; Inert atmosphere;86.6%
With sodium iodide In acetonitrile at 30℃; Inert atmosphere;85%
chloromethyl hexanoate
66542-51-6

chloromethyl hexanoate

A

iodomethyl hexanoate
63379-66-8

iodomethyl hexanoate

B

iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

Conditions
ConditionsYield
With sodium iodide In acetoneA 78%
B n/a
Sodium iodide (dried)

Sodium iodide (dried)

Chloromethyl pivalate
18997-19-8

Chloromethyl pivalate

iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

Conditions
ConditionsYield
In acetonitrile75%
trioxane
188680-60-6

trioxane

pivaloyl chloride
3282-30-2

pivaloyl chloride

iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

Conditions
ConditionsYield
With sodium iodide In hexane; water; acetonitrile66%
Chloromethyl pivalate
18997-19-8

Chloromethyl pivalate

acetyl chloride
75-36-5

acetyl chloride

iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

Conditions
ConditionsYield
With sodium iodide In acetone
C18H18O4

C18H18O4

iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

C24H28O6

C24H28O6

Conditions
ConditionsYield
With N-ethyl-N,N-diisopropylamine100%
(6R,7S,Z)-7-(2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(trityloxyimino)acetamido)-8-oxo-3-(trifluoromethylsulfonyloxy)-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid
1147849-04-4

(6R,7S,Z)-7-(2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(trityloxyimino)acetamido)-8-oxo-3-(trifluoromethylsulfonyloxy)-1-aza-bicyclo[4.2.0]oct-2-ene-2-carboxylic acid

iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

(6R,7S,Z)-pivaloyloxymethyl 7-(2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(trityloxyimino)acetamido)-8-oxo-3-(trifluoromethylsulfonyloxy)-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate
1147849-85-1

(6R,7S,Z)-pivaloyloxymethyl 7-(2-(5-amino-1,2,4-thiadiazol-3-yl)-2-(trityloxyimino)acetamido)-8-oxo-3-(trifluoromethylsulfonyloxy)-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

Conditions
ConditionsYield
With tetra-(n-butyl)ammonium iodide; triethylamine In N,N-dimethyl-formamide at 0℃; for 0.833333h;100%
dimethyl 2-benzylidenepropanedioate
6626-84-2

dimethyl 2-benzylidenepropanedioate

iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

dimethyl 2-hydroxymethyl-2-(1-phenyl-2-pivaloyloxyethyl)malonate
1383105-29-0

dimethyl 2-hydroxymethyl-2-(1-phenyl-2-pivaloyloxyethyl)malonate

Conditions
ConditionsYield
With tert.-butylhydroperoxide; boron trifluoride diethyl etherate; dimethyl zinc(II) In decane; hexane; dichloromethane at 20℃; for 3h; Cooling with ice;99%
iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

dimethyl 2-(4-chlorobenzylidene)malonate
52927-44-3

dimethyl 2-(4-chlorobenzylidene)malonate

dimethyl 2-(1-(4-chlorophenyl)-2-pivaloyloxyethyl)-2-hydroxymethylmalonate
1383105-33-6

dimethyl 2-(1-(4-chlorophenyl)-2-pivaloyloxyethyl)-2-hydroxymethylmalonate

Conditions
ConditionsYield
With tert.-butylhydroperoxide; boron trifluoride diethyl etherate; dimethyl zinc(II) In decane; hexane; dichloromethane at 20℃; for 4h; Cooling with ice;99%
iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

dimethyl 2-(4-methoxybenzylidene)malonate
7443-25-6

dimethyl 2-(4-methoxybenzylidene)malonate

dimethyl 2-hydroxymethyl-2-(1-(4-methoxyphenyl)-2-pivaloyloxyethyl)malonate
1383105-35-8

dimethyl 2-hydroxymethyl-2-(1-(4-methoxyphenyl)-2-pivaloyloxyethyl)malonate

Conditions
ConditionsYield
With tert.-butylhydroperoxide; boron trifluoride diethyl etherate; dimethyl zinc(II) In decane; hexane; dichloromethane at 20℃; for 4h; Cooling with ice;99%
iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

5-[(2S,3S)-1-{trans-4-[1-(tert-butoxycarbonyl)amino-2-fluoroethyl]cyclohexanecarbonyl}-3-cyclohexylpyrrolidine-2-carboxamide]-1-benzofuran-2-carboxylic acid

5-[(2S,3S)-1-{trans-4-[1-(tert-butoxycarbonyl)amino-2-fluoroethyl]cyclohexanecarbonyl}-3-cyclohexylpyrrolidine-2-carboxamide]-1-benzofuran-2-carboxylic acid

[(2,2-dimethylpropanoyl)oxy]methyl 5-[(2S,3S)-1-{trans-4-[1-(tert-butoxycarbonyl)amino-2-fluoroethyl]cyclohexanecarbonyl}-3-cyclohexylpyrrolidine-2-carboxamide]-1-benzofuran-2-carboxylate

[(2,2-dimethylpropanoyl)oxy]methyl 5-[(2S,3S)-1-{trans-4-[1-(tert-butoxycarbonyl)amino-2-fluoroethyl]cyclohexanecarbonyl}-3-cyclohexylpyrrolidine-2-carboxamide]-1-benzofuran-2-carboxylate

Conditions
ConditionsYield
With potassium carbonate In N,N-dimethyl-formamide at 20℃; for 18h;99%
iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

cefditoren
104145-95-1

cefditoren

cefditoren pivoxil
117467-28-4

cefditoren pivoxil

Conditions
ConditionsYield
Stage #1: cefditoren With pyridine In N,N-dimethyl-formamide at -10℃;
Stage #2: iodomethyl pivaloate at -10℃; for 1h;
98.75%
With triethylamine In tetrahydrofuran at 12℃; for 0.5h; Temperature;55.6 g
N-(benzylidene)-p-methylbenzenesulfonamide
51608-60-7

N-(benzylidene)-p-methylbenzenesulfonamide

iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

N-(2-pivaloyloxy-1-phenylethyl)-4-toluenesulfonamide
1049016-44-5

N-(2-pivaloyloxy-1-phenylethyl)-4-toluenesulfonamide

Conditions
ConditionsYield
With triethyl borane In hexane; toluene at 20℃; for 21h; Inert atmosphere;98%
With triethyl borane; sodium hydroxide In hexane; dichloromethane at 20℃; for 20h; Inert atmosphere;96%
iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

C24H26N6O7S3

C24H26N6O7S3

cefditoren pivoxil
117467-28-4

cefditoren pivoxil

Conditions
ConditionsYield
Stage #1: C24H26N6O7S3 With tetraethylammonium hydroxide In 1-methyl-pyrrolidin-2-one at 20℃; for 2h;
Stage #2: iodomethyl pivaloate With pyridine In 1-methyl-pyrrolidin-2-one at 0 - 20℃; for 1h;
Stage #3: With t-butyldimethylsiyl triflate In 1-methyl-pyrrolidin-2-one at 0℃; for 0.25h;
96.84%
iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

diphenyldisulfane
882-33-7

diphenyldisulfane

(phenylthio)methyl pivalate

(phenylthio)methyl pivalate

Conditions
ConditionsYield
Stage #1: iodomethyl pivaloate With TurboGrignard In tetrahydrofuran at -78℃; for 0.25h; Inert atmosphere; Schlenk technique;
Stage #2: diphenyldisulfane In tetrahydrofuran at -78 - 25℃; for 2.5h; Inert atmosphere; Schlenk technique;
96%
Stage #1: iodomethyl pivaloate With isopropylmagnesium chloride In tetrahydrofuran at -78℃; for 0.25h; Metallation;
Stage #2: diphenyldisulfane In tetrahydrofuran at -78 - 20℃; Substitution;
81%
iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

benzyl N-benzylidenecarbamate
172794-72-8

benzyl N-benzylidenecarbamate

2-benzyloxycarbonylamino-2-phenylethyl pivalate
1355078-53-3

2-benzyloxycarbonylamino-2-phenylethyl pivalate

Conditions
ConditionsYield
With triethyl borane; sodium hydroxide In hexane; dichloromethane at -60℃; for 6h; Inert atmosphere;96%
iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid
53-86-1

[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid

pivaloyloxymethyl 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolylacetate
99199-42-5

pivaloyloxymethyl 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolylacetate

Conditions
ConditionsYield
Stage #1: [1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid With N,N,N',N'-tetramethylguanidine In N,N-dimethyl acetamide at -10 - 20℃; Inert atmosphere;
Stage #2: iodomethyl pivaloate In N,N-dimethyl acetamide at -20 - -15℃;
95.5%
iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

7-<(Z)-2-(2-Aminothiazol-4-yl)-2-methoxyiminoacetamido>-3(Z)-(4-methylthiazol-5-yl)vinyl-3-cephem-4-carboxylic acid sodium salt
104146-53-4

7-<(Z)-2-(2-Aminothiazol-4-yl)-2-methoxyiminoacetamido>-3(Z)-(4-methylthiazol-5-yl)vinyl-3-cephem-4-carboxylic acid sodium salt

cefditoren pivoxil
117467-28-4

cefditoren pivoxil

Conditions
ConditionsYield
With tetrabutylammomium bromide In dichloromethane; water at 0 - 25℃; for 2h; Reagent/catalyst;95.3%
In N,N-dimethyl-formamide at -35 - -30℃; Solvent; Temperature; Concentration; Large scale;89%
With 18-crown-6 ether; sodium hydrogencarbonate In N,N-dimethyl-formamide at -40 - -35℃; for 5h; Temperature; Darkness;84.2%
2',3',5'-O-triacetyl-6-chloroinosine
5987-73-5

2',3',5'-O-triacetyl-6-chloroinosine

iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

6-(pivaloyloxymethyl)-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)purine

6-(pivaloyloxymethyl)-9-(2,3,5-tri-O-acetyl-β-D-ribofuranosyl)purine

Conditions
ConditionsYield
Stage #1: iodomethyl pivaloate With chloro-trimethyl-silane; 1,1-Dibromoethane; zinc In tetrahydrofuran at 10 - 15℃; for 1h;
Stage #2: 2',3',5'-O-triacetyl-6-chloroinosine With tetrakis(triphenylphosphine) palladium(0) In tetrahydrofuran at 20℃; for 8h; Negishi reaction;
95%
iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

9-[2-deoxy-3,5-di-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl]-6-iodopurine
756494-16-3

9-[2-deoxy-3,5-di-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl]-6-iodopurine

6-(pivaloyloxymethyl)-9-(2-deoxy-3,5-di-O-toluoyl-β-D-erythro-pentofuranosyl)purine
773133-74-7

6-(pivaloyloxymethyl)-9-(2-deoxy-3,5-di-O-toluoyl-β-D-erythro-pentofuranosyl)purine

Conditions
ConditionsYield
Stage #1: iodomethyl pivaloate With chloro-trimethyl-silane; 1,1-Dibromoethane; zinc In tetrahydrofuran at 10 - 15℃; for 1h;
Stage #2: 9-[2-deoxy-3,5-di-O-(4-methylbenzoyl)-β-D-erythro-pentofuranosyl]-6-iodopurine With tetrakis(triphenylphosphine) palladium(0) In tetrahydrofuran at 20℃; for 6h; Negishi reaction;
95%
iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

(S)-3-(((tert-butoxycarbonyl)amino)methyl)-5-methylhexanoic acid
649748-09-4

(S)-3-(((tert-butoxycarbonyl)amino)methyl)-5-methylhexanoic acid

(S)-3-(tert-butoxycarbonylamino-methyl)-5-methyl-hexanoic acid 2,2-dimethyl-propionyloxymethyl ester
1026789-37-6

(S)-3-(tert-butoxycarbonylamino-methyl)-5-methyl-hexanoic acid 2,2-dimethyl-propionyloxymethyl ester

Conditions
ConditionsYield
Stage #1: (S)-3-(((tert-butoxycarbonyl)amino)methyl)-5-methylhexanoic acid With caesium carbonate In methanol at 20℃; for 4h;
Stage #2: iodomethyl pivaloate In acetonitrile at 20℃;
95%
Stage #1: (S)-3-(((tert-butoxycarbonyl)amino)methyl)-5-methylhexanoic acid With caesium carbonate In methanol at 20℃; for 4h;
Stage #2: iodomethyl pivaloate In acetonitrile at 20℃;
95%
iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

benzaldehyde N-boc imine
150884-50-7

benzaldehyde N-boc imine

2-tert-butoxycarbonylamino-2-phenylethyl pivalate
1355078-48-6

2-tert-butoxycarbonylamino-2-phenylethyl pivalate

Conditions
ConditionsYield
With triethyl borane; sodium hydroxide In hexane; dichloromethane at -20℃; for 6h; Inert atmosphere;95%
iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

dimethyl 2-(4-chlorobenzylidene)malonate
52927-44-3

dimethyl 2-(4-chlorobenzylidene)malonate

dimethyl 2-(1-(4-chlorophenyl)-2-pivaloyloxyethyl)malonate
1383105-39-2

dimethyl 2-(1-(4-chlorophenyl)-2-pivaloyloxyethyl)malonate

Conditions
ConditionsYield
With tert.-butylhydroperoxide; boron trifluoride diethyl etherate; dimethyl zinc(II) In decane; hexane; dichloromethane at 20℃; for 1h; Inert atmosphere; Cooling with ice;95%
iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

cefetamet
65052-63-3

cefetamet

(6R,7R)-3-methyl-7-[(Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)-acetamido]-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic acid pivaloyloxymethyl ester hydrochloride

(6R,7R)-3-methyl-7-[(Z)-2-(2-amino-4-thiazolyl)-2-(methoxyimino)-acetamido]-8-oxo-5-thia-1-azabicyclo[4,2,0]oct-2-ene-2-carboxylic acid pivaloyloxymethyl ester hydrochloride

Conditions
ConditionsYield
Stage #1: cefetamet With tetrapropylammonium iodide In 1-methyl-pyrrolidin-2-one at 20℃; for 0.5h;
Stage #2: iodomethyl pivaloate With pyridine In 1-methyl-pyrrolidin-2-one at -10 - 20℃; for 1h;
Stage #3: With hydrogenchloride In water Concentration;
94.86%
iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

C21H25N9O7S2

C21H25N9O7S2

cefteram pivoxil
82547-81-7

cefteram pivoxil

Conditions
ConditionsYield
Stage #1: C21H25N9O7S2 With tetrapropylammonium iodide In 1,4-dioxane at 20℃; for 2h;
Stage #2: iodomethyl pivaloate With pyridine In 1,4-dioxane at -10 - 20℃; for 1h;
Stage #3: With t-butyldimethylsiyl triflate In 1,4-dioxane at 0℃; for 0.25h;
94.86%
potassium (6R,7R)-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3-[(Z)-2-(4-methylthiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

potassium (6R,7R)-7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3-[(Z)-2-(4-methylthiazol-5-yl)ethenyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylate

iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

cefditoren pivoxil
117467-28-4

cefditoren pivoxil

Conditions
ConditionsYield
In dimethyl sulfoxide at -20℃; for 5h;94.7%
iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

N-(4-methoxybenzylidene)-p-toluenesulfonamide
14674-38-5

N-(4-methoxybenzylidene)-p-toluenesulfonamide

N-(2-pivaloyloxy-1-(4-methoxyphenyl)ethyl)-4-toluenesulfonamide
1049016-50-3

N-(2-pivaloyloxy-1-(4-methoxyphenyl)ethyl)-4-toluenesulfonamide

Conditions
ConditionsYield
With triethyl borane; boron trifluoride diethyl etherate In hexane; dichloromethane at 20℃; for 22h; Inert atmosphere;94%
tert-butyl 4-bromobenzylidenecarbamate
479423-43-3

tert-butyl 4-bromobenzylidenecarbamate

iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

2-(4-bromophenyl)-2-tert-butoxycarbonylaminoethyl pivalate
1355078-54-4

2-(4-bromophenyl)-2-tert-butoxycarbonylaminoethyl pivalate

Conditions
ConditionsYield
With triethyl borane; sodium hydroxide In hexane; dichloromethane at -20℃; for 6h; Inert atmosphere;94%
dimethyl 2-benzylidenepropanedioate
6626-84-2

dimethyl 2-benzylidenepropanedioate

iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

dimethyl 2-(1-phenyl-2-pivaloyloxyethyl)malonate
1383105-27-8

dimethyl 2-(1-phenyl-2-pivaloyloxyethyl)malonate

Conditions
ConditionsYield
With tert.-butylhydroperoxide; boron trifluoride diethyl etherate; dimethyl zinc(II) In decane; hexane; dichloromethane at 20℃; for 0.25h; Inert atmosphere; Cooling with ice;94%
(1R,5S,6S)-2-[1-(4-carbamoyl-1,3-thiazol-2-yl)azetidin-3-yl]thio-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid sodium salt

(1R,5S,6S)-2-[1-(4-carbamoyl-1,3-thiazol-2-yl)azetidin-3-yl]thio-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid sodium salt

iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

pivaloyloxymethyl (1R,5S,6S)-2-[1-(4-carbamoyl-1,3-thiazol-2-yl)azetidin-3-yl]thio-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylate

pivaloyloxymethyl (1R,5S,6S)-2-[1-(4-carbamoyl-1,3-thiazol-2-yl)azetidin-3-yl]thio-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylate

Conditions
ConditionsYield
Stage #1: (1R,5S,6S)-2-[1-(4-carbamoyl-1,3-thiazol-2-yl)azetidin-3-yl]thio-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid sodium salt; iodomethyl pivaloate In ISOPROPYLAMIDE at 0℃; for 1h;
Stage #2: With sodium thiosulfate In ISOPROPYLAMIDE; water; ethyl acetate
Stage #3: With sodium hydrogencarbonate In ISOPROPYLAMIDE; water; ethyl acetate
93%
(1R,5S,6S)-2-[1-(4-carbamoyl-1,3-thiazol-2-yl)azetidin-3-yl]thio-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid sodium salt

(1R,5S,6S)-2-[1-(4-carbamoyl-1,3-thiazol-2-yl)azetidin-3-yl]thio-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylic acid sodium salt

iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

pivaloyloxymethyl (1R,5S,6S)-2-[1-(4-carbamoyl-1,3-thiazol-2-yl)azetidin-3-yl]thio-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylate

pivaloyloxymethyl (1R,5S,6S)-2-[1-(4-carbamoyl-1,3-thiazol-2-yl)azetidin-3-yl]thio-6-[(R)-1-hydroxyethyl]-1-methylcarbapen-2-em-3-carboxylate

Conditions
ConditionsYield
In diethyl ether; ISOPROPYLAMIDE; ethyl acetate93%
iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

6-Chloro-9-(2'-deoxy-3',5'-di-O-p-toluyl-α-D-erythro-pentofuranosyl)purine
139244-01-2

6-Chloro-9-(2'-deoxy-3',5'-di-O-p-toluyl-α-D-erythro-pentofuranosyl)purine

6-(pivaloyloxymethyl)-9-(2-deoxy-3,5-di-O-toluoyl-β-D-erythro-pentofuranosyl)purine
773133-74-7

6-(pivaloyloxymethyl)-9-(2-deoxy-3,5-di-O-toluoyl-β-D-erythro-pentofuranosyl)purine

Conditions
ConditionsYield
Stage #1: iodomethyl pivaloate With chloro-trimethyl-silane; 1,1-Dibromoethane; zinc In tetrahydrofuran at 10 - 15℃; for 1h;
Stage #2: 6-Chloro-9-(2'-deoxy-3',5'-di-O-p-toluyl-α-D-erythro-pentofuranosyl)purine With tetrakis(triphenylphosphine) palladium(0) In tetrahydrofuran at 20℃; for 8h; Negishi reaction;
92%
Sodium 7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3-(tetrahydrofuran-3-yl)methylthio-3-cephem-4-carboxylate

Sodium 7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3-(tetrahydrofuran-3-yl)methylthio-3-cephem-4-carboxylate

iodomethyl pivaloate
53064-79-2

iodomethyl pivaloate

pivaloyloxymethyl 7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3-(tetrahydrofuran-3-yl)methylthio-3-cephem-4-carboxylate

pivaloyloxymethyl 7-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]-3-(tetrahydrofuran-3-yl)methylthio-3-cephem-4-carboxylate

Conditions
ConditionsYield
In N-methyl-acetamide; water92%

53064-79-2Downstream Products

53064-79-2Relevant articles and documents

Cellular delivery of nucleoside diphosphates: A prodrug approach

Kang, Shin Hong,Sinhababu, Achintya K.,Cory, Joseph G.,Mitchell, Beverly S.,Thakker, Dhiren R.,Cho, Moo J.

, p. 706 - 712 (1997)

Purpose. This study is concerned with cellular delivery/generation of 2'-azido-2'-deoxyuridine and -deoxycytidine diphosphate (N3UDP or N3CDP), potent inhibitors of ribonucleotide reductase. It characterizes the phosphorylation steps involved in the conversion of 2'-azido-2'-deoxyuridine (N3Urd) and 2'-azido-2'-deoxycytidine (N3Cyd) to the corresponding diphosphates and explores a prodrug approach in cellular delivery of the inhibitor which circumvents the requirement of deoxynucleoside kinases. Methods. Cell growth of CHO and 3T6 cells of known deoxycytidine kinase level was determined in the presence of N3Urd and N3Cyd. Activity of ribonucleotide reductase was determined in the presence of the azidonucleosides as well as their mono- or di-phosphates in a Tween 80-containing permeabilizing buffer. A prodrug of 5'-monophosphate of N3Urd was prepared and its biological activity was evaluated with CHO cells as well as with cells transfected with deoxycytidine kinase. Results. N3Urd failed to inhibit the growth of both cell lines, while N3Cyd was active against 3T6 cells and moderately active against CHO cells. These results correlate with the deoxycytidine kinase levels found in the cells. Importance of the kinase was further established with the finding that the nucleoside analogs were inactive as reductase inhibitors in a permeabilized cell assay system while their mono- and di-phosphates were equally active. The prodrug was active in cell growth inhibition regardless of the deoxycytidine kinase level. Conclusions. The azidonucleosides become potent inhibitors of the reductase by two sequential phosphorylation steps. The present study indicates that the first step to monophosphate is rate-limiting, justifying a prodrug approach with the monophosphate.

Esterase-Activatable Synthetic M+/Cl? Channel Induces Apoptosis and Disrupts Autophagy in Cancer Cells

Malla, Javid Ahmad,Sharma, Virender Kumar,Lahiri, Mayurika,Talukdar, Pinaki

supporting information, p. 11946 - 11949 (2020/08/27)

The formation of a supramolecular synthetic M+/Cl? channel in the membrane phospholipid bilayer has been reported upon activation of a methyl pivalate-linked N1,N3-dialkyl-2-hydroxyisophthalamide by esterases. The channel formation induces apoptosis in cancer cells via the intrinsic pathway. Interestingly, the supramolecular channel was also shown to disrupt autophagy in cancer cells by causing alkalization of lysosomes – a feature that has been confirmed at the cellular and protein level.

An improved synthesis of adefovir and related analogues

Jones, David J.,O’Leary, Eileen M.,O’Sullivan, Timothy P.

supporting information, p. 801 - 810 (2019/04/17)

An improved synthesis of the antiviral drug adefovir is presented. Problems associated with current routes to adefovir include capricious yields and a reliance on problematic reagents and solvents, such as magnesium tert-butoxide and DMF, to achieve high conversions to the target. A systematic study within our laboratory led to the identification of an iodide reagent which affords higher yields than previous approaches and allows for reactions to be conducted up to 10 g in scale under milder conditions. The use of a novel tetrabutylammonium salt of adenine facilitates alkylations in solvents other than DMF. Additionally, we have investigated how regioselectivity is affected by the substitution pattern of the nucleobase. Finally, this chemistry was successfully applied to the synthesis of several new adefovir analogues, highlighting the versatility of our approach.

Preparation method of iodomethyl pivalate

-

Paragraph 0011; 0012, (2017/02/24)

The invention discloses a preparation method of iodomethyl pivalate as an important medicine intermediate. The preparation method is characterized in that iodomethyl pivalate as a raw material and sodium iodide undergo a replacement reaction in ethyl acetate as a solvent under the condition of reaction backflow time of 6h. Compared with other synthesis methods, the preparation method of iodomethyl pivalate has a high mole yield. The iodomethyl pivalate obtained by the preparation method has product purity (GC) of 98% and thus the product has advantages in cost and purity.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 53064-79-2